5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
pantoprazole sodium
Conditions | Yield |
---|---|
With sodium hydroxide In water; acetonitrile at 20℃; | 95% |
With sodium hydroxide In ethanol for 5h; Reflux; | 95% |
With sodium hydroxide In water; ethyl acetate at 20℃; for 5.5h; | 92% |
pantoprazole sulfide
pantoprazole sodium
Conditions | Yield |
---|---|
Stage #1: pantoprazole sulfide With sodium hydroxide; tert-butylhypochlorite In dichloromethane; water at 0 - 5℃; for 1h; Stage #2: With sodium hydroxide In water; acetone at 0 - 25℃; for 7h; | 95% |
Stage #1: pantoprazole sulfide With potassium tungstate dihydrate; dihydrogen peroxide at -5 - 0℃; for 4.5h; pH=3.5; Stage #2: With sodium hydroxide In water at 20℃; Temperature; Reagent/catalyst; | 78.7% |
With sodium hypochlorite; sodium hydroxide In methanol; water at -20 - -5℃; | |
Stage #1: pantoprazole sulfide With sodium hypochlorite; sodium hydroxide In water; acetonitrile at -5 - 30℃; Stage #2: With acetic acid In dichloromethane at 25 - 30℃; pH=8 - 8.5; Stage #3: With sodium hydroxide In dichloromethane; water at 25 - 30℃; Concentration; | |
Stage #1: pantoprazole sulfide With sodium hypochlorite; water; sodium hydroxide In ethyl acetate at 0 - 10℃; for 7h; Stage #2: With sodium thiosulfate In ethyl acetate for 0.333333h; |
5-(difluoromethoxy)-2-mercapto-1H-benzimidazole
2-Chloromethyl-3,4-dimethoxy-pyridine; hydrochloride
pantoprazole sodium
Conditions | Yield |
---|---|
Stage #1: 5-(difluoromethoxy)-2-mercapto-1H-benzimidazole; 2-Chloromethyl-3,4-dimethoxy-pyridine; hydrochloride With sodium hydroxide; tetrabutylammomium bromide In dichloromethane; water at 25 - 30℃; for 12h; Stage #2: With sodium hydroxide; sodium hypochlorite In dichloromethane; water at 0 - 8℃; for 6h; Product distribution / selectivity; | 83% |
5-(difluoromethoxy)-2-mercapto-1H-benzimidazole
pantoprazole sodium
Conditions | Yield |
---|---|
Stage #1: 2-hydroxymethyl-3,4-dimethoxypyridine hydrochloride With thionyl chloride In dichloromethane at 0 - 15℃; for 1h; Stage #2: 5-(difluoromethoxy)-2-mercapto-1H-benzimidazole With sodium hydroxide; tetrabutylammomium bromide In dichloromethane; water at 10 - 30℃; for 12h; pH=10 - 11; Stage #3: With sodium hydroxide; sodium hypochlorite In dichloromethane; water at 0 - 8℃; for 6h; Product distribution / selectivity; | 79.6% |
(5-difluoromethoxy)-2-[(4-chloro-3-methoxy-2-pyridinyl)methyl]thio-1H-benzimidazole
sodium methylate
pantoprazole sodium
Conditions | Yield |
---|---|
In methanol at 50℃; Heating / reflux; | 70.8% |
5-(difluoromethoxy)-2-[[(4-chloro-3-methoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
pantoprazole sodium
Conditions | Yield |
---|---|
With sodium methylate In methanol at 50℃; Heating / reflux; | 70.8% |
pantoprazole sulfide
B
pantoprazole sodium
Conditions | Yield |
---|---|
With sodium hydroxide; sodium hypochlorite In water; ethyl acetate at -5℃; for 1 - 1.5h; Product distribution / selectivity; | A n/a B 65% C n/a |
5-(difluoromethoxy)-2-mercapto-1H-benzimidazole
pantoprazole sodium
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: sodium hydroxide / ethanol / 8 h / 80 °C 2: 3-chloro-benzenecarboperoxoic acid / chloroform / 4 h / 0 °C 3: sodium hydroxide / ethanol / 5 h / Reflux View Scheme | |
Multi-step reaction with 3 steps 1: sodium hydroxide / water; methanol / 3.5 h / 40 - 55 °C 2: LACTIC ACID; peracetic acid / methanol; dichloromethane / 1 h / -25 - -20 °C 3: sodium hydroxide / water; acetone / 40 - 45 °C View Scheme |
sodium hydroxide
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
pantoprazole sodium
Conditions | Yield |
---|---|
In water; acetonitrile at 25 - 35℃; for 1h; | |
In ethanol; dichloromethane; water at 20℃; pH=12.5; Product distribution / selectivity; |
5-(difluoromethoxy)-2-mercapto-1H-benzimidazole
pantoprazole sodium
Conditions | Yield |
---|---|
Stage #1: 2-chloromethyl-3,4-dimethoxypyridine hydrochloride; 5-(difluoromethoxy)-2-mercapto-1H-benzimidazole With sodium hydroxide In ethanol; water at 35℃; for 2h; Stage #2: With sodium borate In ethanol at 45℃; for 2h; Stage #3: With dihydrogen peroxide In water at 20℃; for 2.5h; Concentration; Temperature; | 19.61 g |
pantoprazole sodium
Conditions | Yield |
---|---|
With zinc(II) chloride In water at 20℃; for 1.5h; | 95% |
pantoprazole sodium
Conditions | Yield |
---|---|
Stage #1: pantoprazole sodium With sodium hydroxide In water at 25℃; for 1h; Stage #2: With magnesium chloride In water at 25℃; for 1h; | 94.6% |
pantoprazole sodium
zinc(II) chloride
Conditions | Yield |
---|---|
Stage #1: pantoprazole sodium With sodium hydroxide In water at 25℃; for 1h; Stage #2: zinc(II) chloride In water at 25℃; for 20h; | 94.2% |
(S)-1,1,2-triphenyl-1,2-ethanediol
pantoprazole sodium
Conditions | Yield |
---|---|
With acetic acid In ethanol for 0.5h; pH=7 - 8; Reflux; Industrial scale; | 94% |
pantoprazole sodium
Conditions | Yield |
---|---|
With water In tert-butyl methyl ether at 20 - 30℃; for 12h; Product distribution / selectivity; | 92.4% |
With water In di-isopropyl ether at 20 - 30℃; for 1 - 12h; Product distribution / selectivity; | 91.93% |
With water In diethyl ether at 20 - 30℃; for 12h; Product distribution / selectivity; | 91.93% |
With water at 0 - 35℃; Product distribution / selectivity; | 91.4% |
With water In dichloromethane at 25 - 35℃; for 1.5h; Product distribution / selectivity; |
pantoprazole sodium
Conditions | Yield |
---|---|
Stage #1: pantoprazole sodium With sodium hydroxide In water at 25℃; for 1h; Stage #2: With calcium chloride In water at 25℃; for 20h; | 91.8% |
pantoprazole sodium
Conditions | Yield |
---|---|
With calcium chloride In water at 20℃; for 1.91667h; | 73% |
pantoprazole sodium
Conditions | Yield |
---|---|
Stage #1: pantoprazole sodium With sodium hydroxide In water at 25℃; for 0.25h; Stage #2: With magnesium chloride In water at 25℃; for 2.5h; | 52.7% |
pantoprazole sodium
Conditions | Yield |
---|---|
With magnesium chloride In water at 20 - 30℃; for 21 - 22h; |
pantoprazole sodium
Conditions | Yield |
---|---|
With sodium hydroxide In ethanol for 24h; Heating / reflux; | |
In tert-butyl methyl ether; acetonitrile at 20℃; for 48h; | |
at 100℃; |
3-chlorosulfonylbenzoic acid 2-(toluene-4-sulfonyl)ethyl ester
pantoprazole sodium
B
3-[6-difluoromethoxy-2-{(3,4-dimethoxy-pyridin-2-yl)-methanesulfinyl}-benzimidazole-1-sulfonyl]benzoic acid 2-(toluene-4-sulfonyl)ethyl ester
Conditions | Yield |
---|---|
With sodium hydrogencarbonate; triethylamine In dichloromethane at 20℃; for 1.5h; |
(4-chlorosulfonylphenoxy)acetic acid 2-(toluene-4-sulfonyl)ethyl ester
pantoprazole sodium
B
4-[6-difluoromethoxy-2-{(3,4-dimethoxypyridin-2-yl)methanesulfinyl}benzimidazole-1-sulfonyl]phenoxyacetic acid 2-(toluene-4-sulfonyl)ethyl ester
Conditions | Yield |
---|---|
With sodium hydrogencarbonate; triethylamine In dichloromethane | |
With sodium hydrogencarbonate; triethylamine In dichloromethane Inert atmosphere; |
pantoprazole sodium
A
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)-chloromethyl]sulfinyl]-1H-benzimidazole
B
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)chlorohydroxymethyl]sulfinyl]-1H-benzimidazole
Conditions | Yield |
---|---|
With sodium hydroxide; sodium hypochlorite In water; acetonitrile at 20℃; for 12h; |
pantoprazole sodium
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
Conditions | Yield |
---|---|
Stage #1: pantoprazole sodium With ethanol Stage #2: With water |
pantoprazole sodium
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt monohydrate
Conditions | Yield |
---|---|
In acetone Purification / work up; Heating / reflux; | |
With water In ethyl acetate; acetone at 0 - 55℃; for 2.25h; Product distribution / selectivity; | |
With water In ethyl acetate at 0 - 5℃; for 2h; Product distribution / selectivity; |
pantoprazole sodium
Conditions | Yield |
---|---|
With water In ethyl acetate; acetone at 0 - 55℃; for 2.25h; Product distribution / selectivity; | |
With water In ethyl acetate at 0 - 5℃; for 2h; Product distribution / selectivity; |
(4-chlorosulfonylphenoxy)acetic acid 2-(toluene-4-sulfonyl)ethyl ester
pantoprazole sodium
Conditions | Yield |
---|---|
Stage #1: (4-chlorosulfonylphenoxy)acetic acid 2-(toluene-4-sulfonyl)ethyl ester; pantoprazole sodium With sodium hydrogencarbonate; triethylamine In dichloromethane Inert atmosphere; Stage #2: With water; sodium hydrogencarbonate In acetonitrile at 65℃; for 5h; Inert atmosphere; |
Conditions | Yield |
---|---|
In water |
The Pantoprazole sodium, with the CAS registry number 138786-67-1, is also known as 1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1). It belongs to the product categories of Active Pharmaceutical Ingredients; Antibiotic Explorer; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; Pantoprazole; Aromatics; Heterocycles; Sulfur & Selenium Compounds. This chemical's molecular formula is C16H15F2N3NaO4S and molecular weight is 406.36. What's more, its systematic name is 5-(Difluoromethoxy)-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl}-1H-benzimidazole - sodium (1:1). Its classification code is Drug / Therapeutic Agent. This chemical is an antiulcerative and a gastric pump inhibitor.
When you are using this chemical, please be cautious about it as the following:
This chemical is harmful by inhalation, in contact with skin and if swallowed. It is irritating to respiratory system and skin. This substance has a risk of serious damage to eyes and has a danger of serious damage to health by prolonged exposure. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. You should not breathe dust. When using it, you need wear suitable protective clothing, gloves and eye/face protection. In case of accident or if you feel unwell, you should seek medical advice immediately (show the label where possible).
You can still convert the following datas into molecular structure:
(1)SMILES: COc1ccnc(c1OC)CS(=O)c2[nH]c3ccc(cc3n2)OC(F)F.[NaH]
(2)Std. InChI: InChI=1S/C16H15F2N3O4S.Na.H/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16;;/h3-7,15H,8H2,1-2H3,(H,20,21);;
(3)Std. InChIKey: WOLQSLCSAWUFCD-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 395mg/kg (395mg/kg) | Drugs of the Future. Vol. 15, Pg. 801, 1990. | |
mouse | LD50 | oral | > 1gm/kg (1000mg/kg) | Drugs of the Future. Vol. 15, Pg. 801, 1990. | |
rat | LD50 | intravenous | 256mg/kg (256mg/kg) | Drugs of the Future. Vol. 15, Pg. 801, 1990. | |
rat | LD50 | oral | 747mg/kg (747mg/kg) | Drugs of the Future. Vol. 15, Pg. 801, 1990. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View